HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by ERn Financial LLC

ERn Financial LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.0% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,814 shares of the company’s stock after selling 57 shares during the quarter. ERn Financial LLC’s holdings in HCA Healthcare were worth $737,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Swedbank AB grew its holdings in HCA Healthcare by 1.2% during the 3rd quarter. Swedbank AB now owns 286,219 shares of the company’s stock worth $116,328,000 after acquiring an additional 3,436 shares in the last quarter. Norway Savings Bank increased its holdings in HCA Healthcare by 24.5% in the third quarter. Norway Savings Bank now owns 1,821 shares of the company’s stock valued at $740,000 after buying an additional 358 shares during the last quarter. Creative Planning lifted its holdings in HCA Healthcare by 37.6% during the 3rd quarter. Creative Planning now owns 47,589 shares of the company’s stock worth $19,342,000 after buying an additional 13,015 shares during the last quarter. CX Institutional increased its holdings in shares of HCA Healthcare by 547.0% in the 3rd quarter. CX Institutional now owns 13,522 shares of the company’s stock valued at $5,496,000 after acquiring an additional 11,432 shares during the last quarter. Finally, Oliver Luxxe Assets LLC acquired a new position in HCA Healthcare in the third quarter worth $4,853,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,202 shares of company stock valued at $6,407,273. Company insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on HCA shares. KeyCorp assumed coverage on shares of HCA Healthcare in a report on Friday, October 11th. They issued an “overweight” rating and a $475.00 price target for the company. Oppenheimer increased their price target on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Barclays upped their price objective on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 24th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. Finally, Leerink Partners boosted their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $365.65.

HCA Healthcare Stock Up 1.4 %

NYSE HCA opened at $401.26 on Wednesday. The company has a market capitalization of $105.10 billion, a P/E ratio of 20.00, a PEG ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $411.87. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company’s 50 day simple moving average is $389.03 and its 200 day simple moving average is $348.47.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same period in the previous year, the firm earned $4.29 earnings per share. HCA Healthcare’s revenue for the quarter was up 10.3% compared to the same quarter last year. Equities research analysts expect that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a $0.66 dividend. The ex-dividend date was Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.66%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.